Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan-Nan Lin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Cardiovascular Medicine|November 21, 2022
Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devicesJin-Yan Ke, Lu-Shen Jin, Yuan-Nan Lin, et al.
Frontiers in Cardiovascular Medicine|December 12, 2022
Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombusLu-Shen Jin, Jin-Yan Ke, Yuan-Nan Lin, et al.
International Immunopharmacology|October 15, 2024
Macrophage-derived VEGF-C reduces cardiac inflammation and prevents heart dysfunction in CVB3-induced viral myocarditis via remodeling cardiac lymphatic vesselsYi-Lian Chen, Yuan-Nan Lin, Jing Xu, et al.
JACC. Basic to Translational Science|April 28, 2026
Cardiomyocyte-Derived Apelin Rescues Viral Myocarditis-Induced Cardiac Lymphatic Dysfunction and RemodelingYuan-Nan Lin, Jing Xu, Yi-Hao Wu, et al.
Frontiers in Pharmacology|March 8, 2024
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillationYang-Qi Pan, Lu-Shen Jin, Sang Qian, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Cardiovascular Medicine|November 21, 2022
Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devicesJin-Yan Ke, Lu-Shen Jin, Yuan-Nan Lin, et al.
Frontiers in Cardiovascular Medicine|December 12, 2022
Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombusLu-Shen Jin, Jin-Yan Ke, Yuan-Nan Lin, et al.
International Immunopharmacology|October 15, 2024
Macrophage-derived VEGF-C reduces cardiac inflammation and prevents heart dysfunction in CVB3-induced viral myocarditis via remodeling cardiac lymphatic vesselsYi-Lian Chen, Yuan-Nan Lin, Jing Xu, et al.
JACC. Basic to Translational Science|April 28, 2026
Cardiomyocyte-Derived Apelin Rescues Viral Myocarditis-Induced Cardiac Lymphatic Dysfunction and RemodelingYuan-Nan Lin, Jing Xu, Yi-Hao Wu, et al.
Frontiers in Pharmacology|March 8, 2024
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillationYang-Qi Pan, Lu-Shen Jin, Sang Qian, et al.
Pageof 2